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Abstract 
Market demands for monoclonal antibodies (mAbs) are steadily increasing worldwide. As a result, production pro‑
cesses using Chinese hamster ovary cells (CHO) are in the focus of ongoing intensification studies for maximizing 
cell‑specific and volumetric productivities. This includes the optimization of animal‑derived component free (ADCF) 
cultivation media as part of good cell culture practice. Dipeptides are known to improve CHO culture performance. 
However, little or even conflicting assumptions exist about their putative import and functionality inside the cells. A 
set of well‑known performance boosters and new dipeptide prospects was evaluated. The present study revealed 
that dipeptides are indeed imported in the cells, where they are decomposed to the amino acids building blocks. 
Subsequently, they are metabolized or, unexpectedly, secreted to the medium. Monoclonal antibody production 
boosting additives like l‑alanine‑l‑glutamine (AQ) or glycyl‑l‑glutamine (GQ) can be assigned to fast or slow dipeptide 
uptake, respectively, thus pinpointing to the need to study dipeptide kinetics and to adjust their feeding individually 
for optimizing mAb production.
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Introduction
Global biopharmaceutical markets are steadily increas-
ing by 3–5 % per year. Markets for monoclonal antibod-
ies (mAb), which are predominantly produced in Chinese 
hamster ovary cells (CHO), show even higher yearly 
growth rates (Walsh 2010; Aggarwal 2012, 2014). To cope 
with market demands, productivity of CHO-based mAb 
production has risen more than 100-fold since the 1990s 
(Birch and Racher 2006; Wurm 2004), currently reach-
ing 2–5  g/L (and more) in 12  day-cultivations (Schaub 
et  al. 2012). Maximum cell-specific productivities were 
recently published by Tabuchi and Sugiyama (2013) 
reporting >100 pg/cell/day.
This rise of performance data is the result of successful 
strain engineering in combination with process optimi-
zation. The latter mirrors all activities of process inten-
sification using batch, fed-batch and continuous mode 
operations, with or without cell retention, in perfusion 
reactors (Jain and Kumar 2008). Certainly, medium opti-
mization plays a decisive role for establishing best growth 
and production conditions in intensified bioprocesses. In 
essence, medium optimization should always aim at pro-
viding the best nutrient composition, maintaining rea-
sonable prices, reproducible quality and easy access.
The ongoing search for animal-derived component free 
(ADCF) media aims at compositions achieving equal or 
even improved productivity performances compared to 
previous complex media (Hayashi and Sato 1976; Bot-
tenstein and Sato 1979; Nakabayashi et al. 1982; Keen and 
Rapson 1995; Heidemann et al. 2000). Due to their diver-
sity and their different boosting properties, dipeptides 
emerge as feasible defined medium components able to 
improve cell productivities. Dipeptides such as l-alanyl-
l-glutamine (AQ) supplanted the use of heat-sensitive 
glutamine (Minamoto et  al. 1991; Atanassov et  al. 1998; 
Imamoto et al. 2010; Kim et al. 2012a, b; Imamoto et al. 
2013). Glycyl-l-glutamine (GQ) additions were studied, 
revealing beneficial effects in murine hybridoma cell cul-
tures (Christie and Butler 1994). l-tyrosine–containing 
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dipeptides were also investigated as solubility of aromatic 
amino acids could be increased up to 250-fold in dipep-
tide configurations (l-tyrosyl-l-histidine (YH); Furst 
1998). Recently, Kang et  al. (2012) presented a compre-
hensive study about the industrial performance of CHO 
after dipeptide addition. Using l-tyrosyl-l-lysine (YK), 
l-tyrosyl-l-histidine (YH), l-tyrosyl-l-alanine (YA), 
l-tyrosyl-l-valine (YV), l-threonyl-l-phenylalanine (TF), 
l-histidyl-l-glycine (HG), and glycyl-l-histidine (GH), 
tyrosine containing dipeptides caused positive effects on 
culture viability and product titer. Non-tyrosine contain-
ing cultures showed variable phenotypes. Other studies 
by Franek and Katinger (2002) and Franek et  al. (2003) 
reported beneficial effects of l-lysine containing peptides.
Although the history of dipeptide clearly outlines 
benefits for additives such as l-alanyl-l-glutamine or 
l-tyrosyl-X, a thorough mechanistic understanding of 
their intracellular functioning and fate is still missing. 
Fractionation studies by Christie and Butler (1994) indi-
cated the strong impact of extracellular hydrolysis in 
murine hybridoma cells studying the utilization of l-ala-
nyl-l-glutamine and glycyl-l-glutamine. On the contrary, 
Kang et al. (2012) recently anticipated that …the observed 
fast clearance may reflect rapid transport of dipeptides 
into the cell rather than hydrolysis… Apparently, the pic-
ture of dipeptides utilization, their functioning and fate 
inside the cells is rather unclear.
Hence, it is the motivation of this contribution to shed 
some light on the utilization of dipeptides by CHO cells. 
The l-glutamine containing additives l-alanyl-l-glu-
tamine (AQ) and glycyl-l-glutamine (GQ) were studied 
as well as tyrosine containing compounds l-alanyl-l-ty-
rosine (AY), glycyl-l-tyrosine (GY) and l-prolinyl-l-ty-
rosine (PY). For comparison, other peptides were applied 
too: l-alanyl-l-cysteine (AC), l-alanyl-l-proline (AP), 
and l-prolinyl-l-cysteine (PC). Fundamental uptake 
kinetics were monitored for all peptides, and attention-
grabbing dipeptides were selected for thorough intra-
cellular studies. Resulting intracellular and extracellular 
kinetics showed that dipeptides are indeed imported into 
the cells and cleaved into their constitutive amino acids, 




Dipeptides were supplied by Evonik Nutrition & Care 
GmbH, Essen, Germany (List in Additional file 1); amino 
acid standards and reagents were supplied by Sigma–
Aldrich (Taufkirchen, Germany). MS-grade water and 
MS-grade acetonitrile was purchased from Carl Roth 
(Essen, Germany). Amino acids and dipeptide standard 
stock solutions were prepared in LC–MS water and 
stored at 70 °C.
Batch CHO cell cultures
The IgG1 producing strain CHO DP12#1934 (ATCC) was 
used for all experiments. Precultures were grown in TC42 
medium (TeutoCell, Bielefeld, Germany) with 200  nM 
methotrexate (MTX) and 4  mM  l-glutamine to a den-
sity of 0.4 ×  106 viable cells/mL. Aliquots were used to 
inoculate the main batch cultivations, again using TC42 
TeutoCell medium with 200 nM MTX as basal medium. 
Selected single dipeptides (provided by Evonik Nutrition 
and Care GmbH, Darmstadt, Germany) were added to the 
main cultures at concentrations ranging from 4 to 6 mM. 
Shaking flasks (125 mL or 2 L), with working volumes of 
40 and 700 mL, were used. Cultures where no dipeptide 
was added to the medium were performed parallel to 
supplemented cultures and considered as reference and 
named “control”. Cells were incubated at 36.5 °C, shaking 
at 140 rpm in 8 % CO2 humidified air for 8–10 days. Sam-
ples were taken daily and cell densities were measured 
through Trypan blue coloration on Cedex (Roche).
Characteristic cell properties were calculated to qualify 
the impact of dipeptide addition to culture performance. 
The cell specific dipeptides uptake rates qS,i of i time 
intervals were estimated in batch cultures according to:
with Δt as the observed time interval, C̄X as the aver-
age cell density of this interval, and CS,n and CS,n-1 as the 
measured dipeptide concentrations at time points n and 
n − 1, respectively.
Cultivations were performed (and analyzed), at least, in 
duplicate.
Sampling and sample treatment for quantification 
of intracellular amino acids and dipeptides
In 700  mL batch cultures, samples containing 32 ×  106 
cells were taken. Cells were centrifuged (1300  rpm, 
10 min, 4 °C) and cell pellets resuspended in 50 mL cold 
PBS (Phosphate buffered saline). Cells were washed twice 
with 5  mL PBS and cell pellets stored at −70  °C until 
cell extraction. Cells were extracted using the Bligh-
Dyer method (Bligh and Dyer 1959) as follows: 1 mL of 
1:2 CHCl3:MeOH was added to the cell pellet, followed 
by 250  µL CHCl3 and 250  µL water vortexed for 5  min 
before each addition. Phase separation was achieved by 
centrifugation (1300 rpm, 10 min, 4 °C). The water layer 
was separated, acidified with 1  % TFA (Trifluoroacetic 
acid), evaporated to dryness using a speed vacuum, and 
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Monoclonal antibody, amino acid and dipeptide 
determination
Antibody concentrations were determined by enzyme-
linked immunosorbent assay (ELISA) using goat anti-
human IgG F(c) as well as goat anti-human kappa 
chain peroxidase conjugated antibody (Rockland, USA) 
and SeramunBlau® (Seramun, Germany) as substrate. 
Absorption at 450  nm was measured by Infinite® 200 
PRO series microplate reader (Tecan, Switzerland). 
Amino acids and dipeptides were analyzed simultane-
ously by LC–MS after dansyl chloride derivatization as 
described below.
Amino acids and dipeptide dansyl chloride derivatization
Dansyl chloride derivatization was used to improve 
amino acids and dipeptide reverse phase chromatog-
raphy retention. The derivatization protocol described 
by Wu et  al. (2013) was used. Medium samples were 
diluted at 1:1500 and 50 µL borax buffer (0.1 M, pH = 9) 
were added to 10 µL of the diluted sample. For intracel-
lular extracts, samples were reconstituted directly with 
60  µL borax buffer. Dansyl chloride (100  µL of 20  mM; 
in acetonitrile) was added and the reaction was kept at 
room temperature for 2 h. Solutions were quenched with 
100 µL 1 % formic acid and measured directly, or stored 
at −20 °C.
LC‑Q‑TOF amino acids and dipeptide quantification
Amino acids and dipeptides were analyzed using an Agi-
lent 1260 Infinity Bio-inert LC system coupled to and 
Agilent 6540 Accurate-Mass Quadrupole. Dipeptide and 
amino acids standards were prepared with concentrations 
ranging from 3 to 4000 µM, calibration ranges with cor-
relation coefficient better than 0.98 were used. Concen-
trations were calculated according to a standard curve. 
Quantification ions are listed in the Additional file  1. 
Analyte identities were confirmed by matching retention 
times and calculated masses with mass accuracy better 
than 1 ppm. The LC system comprised a degasser, quater-
nary pump, and thermostated autosampler (maintained 
at 4  °C). Derivatized samples (10 µL) were injected to a 
reverse phase column and guard column (Aeris PEPTIDE 
3.6 u XBC18 150 × 2.1 mm, Phenomenex) with a flow of 
0.4 mL/min. The mobile-phase A consisted of water with 
0.2  % formic acid, and B, acetonitrile with 0.2  % formic 
acid. The gradient was set to 17 % B at the beginning of 
each run, then increasing up to 80 % B in 10 min followed 
by a washing step and equilibration.
Mass spectrometer was configured in Extended 
Dynamic Range, low mass range (100–1300 m/z). Meas-
urements were made in MS acquisition mode with 
acquisition rate of 2 spectra/s. JetStream electrospray 
ion source was configured with gas temp of 220 °C, and 
sheath gas temperature of 350  °C, drying gas flow 10 L/
min, nebulizer set at 30  lb per square inch gauge, and 
sheath gas flow of 12  L/min. Capillary voltage was set 
to 4000  V, nozzle voltage 0  V, and fragmentor voltage 
to 130 V. Used reference masses were m/z 121.0509 and 
922.0098 and the instrument was recalibrated every 20 
samples.
Data were analyzed using Mass Hunter Workstation 
software (Ver.B.05.519.0, Agilent Technologies), extract-
ing ion chromatograms of the more intense monoiso-
topic ion for each amino acid or dipeptide derivatives.
Statistical analysis
The impact of dipeptide addition on maximal spe-
cific growth rates, mAB cell specific productivity and 
titers were statistically evaluated using a single factor 
ANOVA analysis against a control culture (no dipep-




Cell culture experiments were conducted to test the 
performance of batch cell cultures after addition of the 
individual dipeptides. Taking the cell-specific dipeptide 
uptake rate as a criterion, two distinct phenotypes are 
being observed: group A, showing fast consumption, 
and group B, revealing slow, steady dipeptide uptake (see 
Figs. 1, 2).
AP, GY, AQ, and AY showed fast dipeptide uptake lead-
ing to complete dipeptide depletion after 5  days at the 
latest. Interestingly, this group revealed the highest daily 
cell-specific uptake rates of 1.5–3  µmol ×  10−5/cells at 
the beginning of the batch phase. This phenotype may 
anticipate a diffusion-driven import with highest influx 
coinciding with highest concentration gradients between 
outer and inner conditions.
On the contrary, GQ, PY, AC-CA, and PC-CP showed 
much slower, but rather steady dipeptide consumption 
rates. As indicated, average daily depletion rates were 
about 0.1 µmol × 10−5/cells, which represent 1/10 of the 
values obtained for the ‘fast’ uptaked dipeptides. Appar-
ently, uptake mechanisms for members of group B differ 
from those of group A.
Additionally, maximum cell specific growth and mAb 
production rates were calculated for each supplemented 
batch culture and compared with a control culture (no 
dipeptides added). Figure 3 indicates that the addition of 
peptides from group B tends to slightly reduce the maxi-
mum growth rates in comparison to control, whereas 
dipeptides with fast uptake tend to increase growth.
The analysis of cell-specific mAb production reveals 
that only AQ outperformed, with a maximum cell-specific 
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mAb production rate 34  % higher than the control 
(revealing a borderline statistical relevance). Neverthe-
less, the finding matches the results obtained by Imamoto 
et al. (2013) (Fig. 4a). The highest final concentration was 
obtained with GQ supplementation (+14  % total mAb 
production compared with the control) (Fig. 4b).
Interestingly, the production kinetics of the best boost-
ing dipeptides, AQ and GQ, differ significantly. Figure 5 
shows the relation between viable cell numbers and 
cell-specific productivities. Cultures supplemented with 
AQ revealed maximum productivity qmAb at the begin-
ning, followed by abrupt decrease. On the contrary, GQ 
consumption yielded steady, but lower, qmAb values, in 
combination with an extended period of high viable 
cell densities. Taken together, GQ addition achieved 
increased final mAb titers.
Analyzing intracellular kinetics
Further experiments were performed to elucidate the 
fate of dipeptides that were consumed by the cells. AQ 
and AY were selected as members of group A, enabling 
to revisit former studies (Christie and Butler 1994; Kang 
et al. 2012). AC-CA served as an example of group B. It 
was chosen as an example of an ‘inert’ component pos-
sessing a rather bulky structure with disulfide bonds.
Batch cultivations were performed in 2 L shaking flasks 
(700 mL working volume) to allow sampling of relatively 
high cell numbers, without affecting cell growth. Sam-
ples of 32 × 106 cells were taken, chilled, and three times 
washed (to eliminate unwanted extracellular matrix 
effects) before being extracted to analyze the intracellular 
concentrations of amino acids and dipeptides.
Extracellular and intracellular concentrations of 
selected dipeptides and their constitutive amino acids are 
presented in Figs.  6, 7 and 8 along with the concentra-
tions found in the control.
Uptake kinetics of AQ, AY, and AC-CA (Figs.  6a, 7a, 
8a) showed the same dynamics as already depicted in 
Figs. 1 and 2. Again, AQ and AY turned out to be quickly 
consumed and the depletion of AC-CA was much 
slower. Interestingly, extracellular l-alanine levels stead-
ily increased, whereas AQ (Fig. 6a) and AY (Fig. 7a) were 
consumed. Glutamine was already present in the basal 
medium. Consequently, a steady reduction of Q titers 
was observed, which revealed an intermediary slow-
down between 3 and 5 days. Besides, extracellular tyros-
ine (Y) levels increased along with the alanine courses.
These extracellular courses suggest that dipeptides 
were used by the cells. Glutamine (Q) appeared to be 
consumed internally, whereas A and Y were released, 
Fig. 1 Grouped dipeptides with faster dipeptide uptake rates. Dipeptides concentration in medium (closed circle) decrease with a concentration 
dependent uptake rate (qs, Δ). Error bars describe standard deviation of biological duplicates
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achieving almost identical amino acid levels compared to 
their molar fractions in the dipeptides.
To understand whether dipeptides really entered the 
cells or were cleaved (via extracellular proteases), intra-
cellular measurements were performed (series B in 
Figs.  6, 7, 8). Indeed, AQ and AY were detected inside 
the cells with maximum pool sizes being measured at the 
beginning. Significantly, high levels of separated amino 
acid constituents were also observed, suggesting that 
dipeptides were intracellularly decomposed and their 
amino acids secreted individually.
The basic phenotype of AC-CA uptake was similar to 
AY although slower. Again, alanine (A) turned out to be 
taken up in AC-CA and was likewise secreted. By analogy, 
Fig. 2 Grouped dipeptides with slower dipeptide uptake rates. Dipeptides concentration in medium (closed circle) decrease with slow and constant 
uptake rates (qs, Δ). Error bars describe standard deviation of biological duplicates
Fig. 3 Specific growth rates for dipeptide supplemented CHO cultures compared to non‑supplemented cultures (control). Black bars correspond 
to dipeptide group A showing fast consumption. Grey bars correspond to dipeptides group B revealing slow, steady dipeptide uptake. Error bars 
describe the deviation of duplicates
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cysteine (measured as cystine) revealed a secretion after 
intake. However, intracellular levels of alanine and cystine 
were significantly increased compared to the control.
Discussion
In this study, we controlled the fate of supplemented 
dipeptides not only in the medium but also inside the 
cells. The fact that we found non-degraded dipeptides 
such as AQ, AY and AC-CA in the intracellular matrix 
(Figs. 6, 7, 8, right column B) is taken as a strong evidence 
that dipeptides are imported, rather than degraded by 
extracellular peptidase activity. Figures  1 and 2 already 
indicated different uptake kinetics. Further studies for 
AQ, AY and AC-CA confirmed the fast uptake of AQ and 
AY and the relatively slow uptake of AC-CA (Figs. 6, 7, 
8). The observation of individual uptake kinetics suggests 
the existence of multiple mechanisms for their import. 
Once entered in the cytosol, the dipeptides are degraded 
Fig. 4 Maximal mAb production rates (a) and maximal mAb concentration obtained (b) for CHO dipeptide supplemented cultures compared to 
non‑supplemented cultures (control). Black bars correspond to dipeptide group A showing fast consumption. Grey bars correspond to dipeptides 
group B revealing slow, steady dipeptide uptake. Grey bars correspond to dipeptides group B revealing slow, steady dipeptide uptake. Error bars 
describe the deviation of duplicates
Fig. 5 Fitted curves of specific monoclonal antibody production 
rates (qmAb) and cell growth curves (as viable cell densities, VCD) for 
AQ and GQ dipeptide supplemented cultures
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to their constitutive amino acids and then selectively 
directed to fuel cell metabolisms (such as Q) or surpris-
ingly exported to the culture medium (such as A). An 
overview of the supposed mechanism is given in Fig. 9.
For mammalian cells, two well-known dipeptide 
importers are described (PepT1 and PepT2). But spe-
cific dipeptide importers have not been identified for 
CHO-K1 cells yet (Covitz et al. 1996; Steiner et al. 1995; 
Daniel et  al. 2006; Paulsen and Skurray 1994). How-
ever, PepT1 and PepT2 were assigned in the CHO-K1 
genome as well (Hammond et al. 2012). PepT1 and PepT2 
are known to show different properties with respect 
to uptake kinetic and selectivity (Ito et  al. 2013). PepT1 
is anticipated to enable fast oligopeptide import under 
Fig. 6 CHO culture supplemented with l‑alanyl‑l‑glutamine (AQ). Time courses of the dipeptide and of the related amino acids are monitored in 
the culture medium (a) and in intracellular extracts (b). Open circles represent concentrations found in the control culture which did not have AQ 
supplementation. Error bars describe the standard deviation of three analytical replicates. Extracellular data from single measurements
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relatively high peptide concentrations, whereas PepT2 
should be active under peptide limiting conditions (New-
stead 2014). From our data, two different uptake kinet-
ics were observed. Accordingly, dipeptides were grouped 
in slow and fast uptake, anticipating similarities with 
the PepT1 and PepT2 phenotype (see Figs.  1, 2). Fur-
ther efforts have to be made to identify and characterize 
dipeptide uptake mechanisms in CHO cells.
It was observed that dipeptides like AC-CA, PC-CP, 
and PY were taken up rather slowly. Interestingly, these 
Fig. 7 CHO culture supplemented with l‑alanyl‑l‑tyrosine (AY). Time courses of the dipeptide and of the related amino acids are monitored in the 
culture medium (a) and in intracellular extracts (b). Open circles represent concentrations found in the control culture which did not have AY supple‑
mentation. Error bars describe the standard deviation of three analytical replicates. Extracellular data from single measurements
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compounds have in common rather challenging di-pep-
tide sizes or complex ring structures in the amino acids. 
In this context, the slow uptake rate of GQ is surprising. 
Not only is glycine a small molecule, but both amino 
acids also have rather linear structures that should 
not sterically hamper their uptake. Moreover, Fig.  2 
depicts that G and Q can be imported very fast as part 
of GY and AQ. Apparently, it is not the impact of the 
individual amino acids G (glycine) or Q (l-glutamine) 
themselves that hampers their fast uptake as GQ, but 
their occurrence as a dipeptide that causes the specific 
uptake characteristics. This observation can be taken 
as a hint that dipeptide uptake is very specific and that 
estimations for ‘similar’ compounds based on reference 
Fig. 8 CHO culture supplemented with Alanine‑cystine‑alanine (AC‑CA). Time courses of the dipeptide and of the related amino acids are moni‑
tored in the culture medium (a) and in intracellular extracts (b). Open circles represent concentrations found in the control culture which did not 
have AC‑CA supplementation. Error bars describe the standard deviation of three analytical replicates. Extracellular data from single measurements
Page 10 of 12Sánchez‑Kopper et al. AMB Expr  (2016) 6:48 
substances may result in poor prognosis for the distinct 
cases.
However, some common characteristics of dipeptide 
uptake can be extracted from the experiments: except for 
the rather bulky compound AC-CA, all other l-alanine 
(A) containing dipeptides were taken up very fast. This 
holds true for AP, AQ, and AY (see Fig.  2). Apparently, 
the presence of A in dipeptides eases their fast uptake 
(e.g. compare AQ versus GQ). This may also be true for 
l-tyrosine (Y), which is consumed fast in GY (compared 
to in GQ) and AY, but shows slow uptake properties for 
the relatively bulky dipeptide PY. Kang et al. (2012) also 
found performance improvements when Tyrosine (Y) 
containing dipeptides were added to CHO cultures.
As observed by our intracellular measurements, 
the dipeptides are imported and decomposed in their 
amino acid building blocks (see Fig.  9). Then the indi-
vidual amino acids are either metabolized (such as Q) 
or secreted to the medium (such as A). Figures 6, 7 and 
8 depict the common observation that fast (AQ, AY), as 
well as slow (AC-CA) uptake profile dipeptides cause 
initial increase of intracellular pools, followed by their 
complete disappearance during the course of cultivation. 
Dynamics of intracellular pool rise reflect the decline 
of extracellular dipeptide levels. Notably, the reduc-
tion of intracellular dipeptide pools is accompanied by 
the increase of intracellular levels of the related amino 
acids. Intracellular l-alanine (A) and l-cystine pool sizes 
were significantly higher than in the control experiments 
without dipeptide addition. On the other hand, levels of 
l-glutamine (Q) and l-tyrosine (Y) quickly fell down to 
the intracellular levels of the control cultures which had 
not received dipeptide supplements (see Fig.  6, 7, 8). 
Only an initial increase was observed that coincided with 
the first occurrence of the related dipeptides.
Except for l-glutamine (Q), almost equivalent levels 
of added dipeptides were observed as free extracellu-
lar amino acids during the course of cultivation, which 
indicated their relatively low metabolic demand. On 
the contrary, Q was metabolized immediately inside the 
cells. This was also true for Y, but with a lower level of 
metabolization.
The export of amino acids such as A or C is likely to be 
achieved via the ASC system, that exchanges l-alanine, 
l-serine and l-cysteine via a tertiary active transport 
mechanism from the inside towards the outside (Kyri-
akopoulos et al. 2013). ACS enables the refueling of intra-
cellular, limiting amino acid pools via the export of amble 
ones. Trans-inhibition occurs in case of high extracellu-
lar concentrations of the designated export amino acid, 
whereas trans-activation is found for high driving con-
centration gradients between extra- and intracellular lev-
els of the imported molecules.
As indicated in Fig.  3, the addition of group 1 dipep-
tides (see Fig.  1) did not impair growth rates, even 
showing a slight improvement for AQ. On the contrary, 
group 2 dipeptides slowed down the cellular growth, 
with GQ as the most dominant effector. Regarding 
final mAb titers, the resulting picture is more diverse. 
Although AQ addition did not exceed the control level, 
Fig. 9 Dipeptides are transported by different mechanisms into the intracellular matrix (slow‑constant uptake qs1 and fast‑variable uptake qs2) 
where they are digested and their constitutive amino acids are either used for cell metabolisms (closed circle) or expelled from the cell (open circle)
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GQ supplementation clearly outperformed by 15 %. The 
reason for the benefit of GQ addition is given in Fig. 5. 
When comparing cell-specific mAb productivities of GQ 
and AQ, an early peak of productivity after AQ addition 
is unraveled. However, this maximum productivity could 
not be maintained and reduced quickly during the course 
of cultivation. On the contrary, GQ supplementation did 
not show any peak of performance, but coincided with 
extended periods of high cell viability. Consequently, vol-
umetric productivities were improved after GQ addition, 
especially during phases of low cell growth.
For many decades, AQ and GQ have been applied as 
enhancers for mammalian cell cultures (Minamoto et al. 
1991; Christie and Butler 1994). Indeed, both dipeptides 
boost cellular performance, each of them in their own 
way. Although GQ basically supports growth-decoupled 
product formation, AQ enables maximum cell-specific 
peaks of productivity and accelerates growth. Under-
standing individual dipeptide uptakes and product 
formation kinetics generally opens the door for an inter-
active process optimization. Consequently, the moni-
toring of dipeptide kinetics should be in the center of 
medium and process development in order to optimize 
each process considering cell-specific individuals and 
time-varying nutrient demands.
Furthermore, this study shows that we are only begin-
ning to understand the impact of oligopeptide consump-
tion on cellular physiology and to unravel underlying 
regulatory mechanisms. Current results do show are 
that dipeptides taken up, degraded inside the cells and 
metabolized or secreted afterwards. However, we do not 
know yet which regulatory regimes may be induced after 
dipeptide consumption and further affect cellular activi-
ties. These studies are already under way and may con-
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